Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-22 19:32 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Start: 2013-01. Completion: 2014-08 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide once weekly suspension (drug)
Exenatide twice daily (drug) — also listed as: Byetta
Where the study takes place — 58 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Research Site Muscle Shoals, Alabama, United States Site recruitment: Not reported
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
The University of Texas Health Science Center, Houston
Countries with listed sites
United States
Registry dates and results
Start: 2014-04. Completion: 2017-03 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Saxagliptin (drug) — also listed as: Onglyza
Exenatide extended-release (ER) (drug) — also listed as: Bydureon
Placebo (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The University of Texas Health Science Center at Houston Houston, Texas, United States Site recruitment: Not reported
Start: 2014-06. Completion: 2019-09 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Bydureon (drug) — also listed as: long-acting exenatide
placebo (drug) — also listed as: inactive agent
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Phoenix VA Health Care System Phoenix, Arizona, United States Site recruitment: Not reported
Start: 2017-09-07. Completion: 2017-12-28 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide Injection (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tartu University Hospital Tartu, Estonia Site recruitment: Not reported
Start: 2008-12. Completion: 2015-07 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Exenatide (Byeta)
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Cincinnati Cincinnati, Ohio, United States Site recruitment: Not reported
Start: 2014-01-06. Completion: 2017-11 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Ga -exendin PET/CT, In- exendin SPECT/CT, MRI (other) — also listed as: 68Ga-DOTA-exendin-4, 111In-DOTA-exendin-4, MRI
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University Hospital Basel Basel, Switzerland Site recruitment: Not reported
Start: 2017-02-21. Completion: 2018-04-09 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Radboud university medical centre Nijmegen, Netherlands Site recruitment: Not reported
Start: 2009-08. Completion: 2016-12 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Pramlintide (drug) — also listed as: Symlin
Exenatide (drug) — also listed as: Byetta, Type 1 diabetes
Insulin (drug) — also listed as: Novolog, Humalog, Levemir, Lantus
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Albert Einstein College of Medicine West Campus Clinical Research Center The Bronx, New York, United States Site recruitment: Not reported
Start: 2011-03. Completion: 2015-12-11 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide, Liraglutide (drug) — also listed as: Byetta, Victoza
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Ninewells Hospital Dundee, Angus, United Kingdom Site recruitment: Not reported
Royal Devon and Exeter NHS Foundation Trust Exeter, Devon, United Kingdom Site recruitment: Not reported
Oxford Hospitals NHS Trust Oxford, Oxfordshire, United Kingdom Site recruitment: Not reported
Newcastle Hospitals NHS Trust Newcastle, Teeside, United Kingdom Site recruitment: Not reported
Start: 2015-08-01. Completion: 2015-08-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
exenatide once weekly (drug)
basal insulin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Optum Epidemiology Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2009-09. Completion: 2012-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Saline (drug) — also listed as: 0.9% Saline solution
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
David Greenfield Human Physiology Laboratories Nottingham, Notts, United Kingdom Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
National Institute on Aging, Clinical Research Unit Baltimore, Maryland, United States Site recruitment: Not reported
Start: 2010-12. Completion: 2013-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Medtronic ePID 2.0 (device)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Albert Einstein College of Medicine CRC The Bronx, New York, United States Site recruitment: Not reported
Start: 2013-10. Completion: 2016-09 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug)
Linagliptin (drug)
Gliclazide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
General University Hospital Prague, Czechia Site recruitment: Not reported
Type 2 Diabetes; Healthy; Impaired Glucose Tolerance
Sponsor
The University of Texas Health Science Center at San Antonio
Countries with listed sites
United States
Registry dates and results
Start: 2007-06. Completion: 2010-07 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Pioglitazone (drug) — also listed as: ACTOS
Exenatide (drug) — also listed as: BYETTA
Pioglitazone and Exenatide (drug) — also listed as: ACTOS, BYETTA
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Barter Research Center, ALM VA Hospital San Antonio, Texas, United States Site recruitment: Not reported
Start: 2006-08. Completion: 2010-09 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Glargine Insulin (drug) — also listed as: Lantus insulin
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Joslin Diabetes Center Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2018-01-01. Completion: 2020-06-30 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Acarbose 100 MG (drug) — also listed as: Acarbose
Exenatide (drug)
Orlistat (drug)
Metformin (drug) — also listed as: METF
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Renji Hospital Department of Endocrinology and Metabolism Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Start: 2016-08-15. Completion: 2016-12-15 (may be estimated). No results posted in this registry response.
Products and interventions (0)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Research site Wilmington, Delaware, United States Site recruitment: Not reported
The University of Texas Health Science Center at San Antonio
Countries with listed sites
United States
Registry dates and results
Start: 2010-07. Completion: 2015-07 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Texas Diabetes Institute and UTHSCSA San Antonio, Texas, United States Site recruitment: Not reported
Start: 2011-12. Completion: 2013-02 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Normal saline .2cc subcutaneous injection (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
UCLA Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress Los Angeles, California, United States Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.